Table 2.
Age-Standardized Prevalence of Low-dose Aspirin Use1 Among Adults Aged 40 and Over Eligible2 to Take Low-dose Aspirin for Secondary Prevention of Cardiovascular Disease, by Definition of Atherosclerotic Cardiovascular Disease and Demographic and Health Characteristics, United States, 20123
| Coronary Heart Disease and/or Stroke n=3,068 | Coronary Heart Disease Only n=2,007 | |||
|---|---|---|---|---|
|
| ||||
| % (95% CI) | p-value4 | % (95% CI) | p-value | |
| Total | 62.2% (56.0–68.0) | 67.3% (59.9–74.0) | ||
|
| ||||
| Sex | ||||
| Men | 69.1% (60.8–76.3) | Reference | 73.1% (62.8–81.3) | Reference |
| Women | 55.3% (46.6–63.8) | <0.05 | 60.5% (50.1–70.0) | <0.05 |
|
| ||||
| Race/Ethnicity | ||||
| Non-Hispanic White | 65.5% (57.0–73.2) | Reference | 71.6% (61.2–80.2) | Reference |
| Non-Hispanic Black | 59.3% (47.2–70.3) | NS | 55.9% (38.9–71.6) | NS |
| Hispanic | 50.6% (38.6–62.6) | <0.05 | 53.9% (39.7–67.5) | <0.05 |
| Other | 60.2% (37.3–79.4) | NS | 77.6% (61.6–88.2) | NS |
|
| ||||
| Education | ||||
| <High school | 67.6% (58.4–75.6) | Reference | 68.6% (55.9–79.1) | Reference |
| High school | 56.1% (43.4–67.9) | NS | 67.9% (53.7–79.5) | NS |
| Some college | 56.0% (43.6–67.8) | NS | 61.0% (45.5–74.6) | NS |
| ≥College | 72.7% (59.3–83.0) | NS | 77.6% (63.8–87.2) | NS |
|
| ||||
| BMI | ||||
| Normal | 64.8% (52.6–75.4) | Reference | 63.4% (46.9–77.2) | Reference |
| Overweight | 65.0% (54.2–74.5) | NS | 68.5% (55.5–79.1) | NS |
| Obesity | 58.9% (49.9–67.4) | NS | 69.2% (57.3–79.0) | NS |
|
| ||||
| Insurance Status | ||||
| Yes | 62.6% (55.5–69.2) | Reference | 67.6% (59.0–75.2) | Reference |
| No | 56.2% (42.2–69.3) | NS | 57.4% (41.7–71.7) | NS |
|
| ||||
| Ulcer | ||||
| Yes | 61.9% (50.3–72.4) | Reference | 73.3% (55.4–85.2) | Reference |
| No | 62.4% (55.2–69.0) | NS | 66.2% (57.9–73.7) | NS |
|
| ||||
| Arthritis5 | ||||
| Yes | 61.2% (51.1–70.4) | Reference | 67.5% (53.8–78.8) | Reference |
| No | 62.8% (55.2–69.8) | NS | 66.9% (57.9–74.7) | NS |
|
| ||||
| Number of cardiovascular disease risk factors6 | ||||
| 0 | 37.6% (27.9–48.3) | Reference | 43.8% (27.5–61.7) | Reference |
| 1 | 53.5% (43.0–63.8) | <0.05 | 61.8% (47.7–74.1) | NS |
| 2 | 64.3% (54.1–73.3) | <0.001 | 68.7% (56.7–78.9) | <0.05 |
| 3 | 73.9% (61.7–83.2) | <0.001 | 77.4% (65.0–86.8) | <0.001 |
| 4 | 91.0% (88.4–94.6) | <0.001 | 94.0% (86.4–97.5) | <0.001 |
Including following health care provider's advice to take low-dose aspirin or independently taking low-dose aspirin
An adult's eligibility to take low-dose aspirin is determined by either having been told by a health professional that s/he have coronary heart disease and/or stroke, or having been told by a health professional that s/he has coronary heart disease.
Data source: CDC/NCHS, National Health Interview Survey, 2012
P-values are for comparisons across the categories using reference group, NS – not significant
Arthritis included arthritis, rheumatoid arthritis, gout, lupus, or fibromyalgia
Included self-reported hypertension, high blood cholesterol, diabetes and smoking